Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk von Lewinski

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Trials|August 27, 2020
"Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trialDirk von Lewinski, Joseph B Selvanayagam, Richard A Schatz, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
World Journal of Clinical Cases|July 12, 2024
Better understanding of c-reactive protein and leukocytes in psychiatric inpatients with affective disorders: A biopsychosocial approachFelix Kölblinger, Elena Md Schönthaler, Andreas Baranyi, et al.
Platelets|March 14, 2022
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysisZofia Wicik, Pamela Czajka, Ceren Eyileten, et al.
Cardiology Journal|April 4, 2018
Thermic sealing in femoral catheterization: First experience with the Secure DeviceMichael Sacherer, Ewald Kolesnik, Friederike von Lewinski, et al.
Cardiovascular Diabetology|April 27, 2024
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trialFaisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology|July 20, 2023
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trialFaisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Plos One|August 5, 2016
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood DisorderAndreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, et al.
Pharmacological Research|May 21, 2020
Empagliflozin protects heart from inflammation and energy depletion via AMPK activationChintan N Koyani, Ioanna Plastira, Harald Sourij, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 18, 2018
Use of levosimendan in acute heart failureVeli-Pekka Harjola, George Giannakoulas, Dirk von Lewinski, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Trials|August 27, 2020
"Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trialDirk von Lewinski, Joseph B Selvanayagam, Richard A Schatz, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
World Journal of Clinical Cases|July 12, 2024
Better understanding of c-reactive protein and leukocytes in psychiatric inpatients with affective disorders: A biopsychosocial approachFelix Kölblinger, Elena Md Schönthaler, Andreas Baranyi, et al.
Platelets|March 14, 2022
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysisZofia Wicik, Pamela Czajka, Ceren Eyileten, et al.
Cardiology Journal|April 4, 2018
Thermic sealing in femoral catheterization: First experience with the Secure DeviceMichael Sacherer, Ewald Kolesnik, Friederike von Lewinski, et al.
Cardiovascular Diabetology|April 27, 2024
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trialFaisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology|July 20, 2023
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trialFaisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Plos One|August 5, 2016
Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood DisorderAndreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, et al.
Pharmacological Research|May 21, 2020
Empagliflozin protects heart from inflammation and energy depletion via AMPK activationChintan N Koyani, Ioanna Plastira, Harald Sourij, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 18, 2018
Use of levosimendan in acute heart failureVeli-Pekka Harjola, George Giannakoulas, Dirk von Lewinski, et al.
Pageof 17